Will Cannabis Genetics Be Banned?
A redefinition of hemp under national law, scheduled to take effect Nov. 12, spells the end of Farm Bill safeguards for numerous hemp-derived THC items across the country: low-dose beverages as well as THCA bud and https://nativesusa.com/ (nativesusa.com) delta-8 THC gummies, vapes and other products sold at gas stops and smoke shops.
But the hemp ban also creates a significant complication for the legal cannabis industry. Seeds from cannabis varieties that produce flower with more than 0.3% THC are no longer legal to transport out of state.
Although seed purchases will probably continue in legal states, the changes threaten to close some seed banks and genetics businesses, observers note, while causing supply-chain issues for cannabis cultivators and retailers.
“If this wording goes forward, we will require pop-up stores to offer seeds in each state where it’s permitted,” Campanella said. “Which is why we’re also providing clones and tissue culture, because that’s not included in the bill.”
When are cannabis genetics and clones prohibited to ship between state lines?
The new regulations classify seeds depending on the THC capacity of the parent plant. Genetic material such as seeds and clones are made illegal if the end product exceeds the threshold.
For the moment, seeds are still shipping under the 2018 Farm Bill’s status quo. But the time is ticking for enterprises like Brothers Grimm and for cannabis growers who worry about supply chain disruptions if out-of-state availability to genetics is banned.
Most of the cannabis industry remains mostly unaware of the approaching shutdown of the interstate genetics marketplace, said Ryan Power, co-founder of Sebastopol, California-based company Atlas Seed.
Without government intervention in the form of an exception for seeds or an overall moratorium, many seed suppliers will simply be shuttered by November, he added.
“We are functioning legally now, but if that shifts, it will disrupt the legitimate licensed sector in each state,” said Power, whose clientele includes seed suppliers as well as licensed business cultivators.
“Consumers are going to lose choice, and it will be a significant shutdown for most people.”
What are cannabis seed banks doing to remain legal after the government hemp ban?
Sagui Silber has already recalibrated Silberhaze Genetics, his Ohio genetics business, because of state Senate Bill 56, which tightened cannabis supervision in that state while also limiting hemp-derived THC items to licensed cannabis retailers.
Formerly a seed supplier, Silberhaze is now focused on the marketing, preservation and IP safeguarding of premium plant genetics.
That’s because seed companies hoping to stay compliant in this new environment must have solid documentation, he said.
“You have to prove where this stuff comes from, so it’s extremely important to have documentation, even to the extent where you have breeder names,” Silber said.
“Smaller businesses will have to work with better records and a stronger chain of custody,” he added. “We need that documentation ourselves, because we don’t want to be working with questionable sources.”
To avoid seizures and other legal fallout, seed entrepreneurs must “get their affairs in order” before the new regulations take effect, Silber said.
“Review all your materials immediately, and classify what you can,” Silber said. “Take inventory, document your lineage, preserve breeder records, and organize any cannabinoid or terpene data you already have. If regulations change, you’ll be in a much better position to comprehend what may be affected and make educated decisions.”
Does federal marijuana rescheduling impact cannabis genetics?
Silber believes U.S. Drug Enforcement Administration registration may be required for companies engaged in research.
But for the time being, seed houses can’t register with the DEA like state-licensed therapeutic cannabis businesses can. Such an option is not available to seed suppliers, nurseries or genetics companies, said Jim Ickes, an attorney and partner with Frantz Ward’s cannabis law group in Cleveland.
“Genetics activity may be occurring inside larger state-licensed therapeutic marijuana businesses, as some states allow dispensaries or registered therapeutic operators to sell seeds, clones or home-cultivation materials,” he said.
“But that is different from the DEA creating a freestanding seed supplier registration category.”
Some genetics operators are already changing business practices to comply with the updated law. According to Ickes, they must address questions including:
- Which of our varieties produce plants over 0.3% total THC?
- Which seeds remain as hemp after Nov. 12, 2026, and which don’t?
- What does our catalog look like once we organize it against the genetics exclusion?
Ickes also understands confusion from customers who believed federal rescheduling of medical marijuana would resolve their situation with financial institutions. However, the latest regulatory wording has shifted those conversations beyond the basics of classification, he said.
“Banks ask whether this particular revenue source is legal, whether it ties to state-licensed activity, or whether there’s interstate-commerce risk,” said Ickes.
“After November, a seed supplier selling high-THC genetics can’t answer the first question with the hemp classification. It has to refer to a lawful state cannabis pathway instead. Seed banks dealing in genuine industrial-hemp seed maintain the simpler story.”
What’s the outlook of cannabis genetics?
Campanella is part of a new coalition of fellow breeders, farmers and researchers that’s saying seeds are better defined as farm inputs than controlled substances. To that end, seeds should be overseen by the U.S. Department of Agriculture, leaving the DEA to concentrate its enforcement work elsewhere.
“How do you control something based on what it could become later?” said Campanella. “Our choice is to have that language removed, or get seeds regulated by the USDA as a hemp product.”
But in the meantime, Campanella is restructuring Brothers Grimm to operate outside the scope of changing federal oversight. The business plans to keep its Colorado seed facility while positioning its Oklahoma tissue culture facility as a hedge against federal prohibition of cannabis seeds.
As she noted: “If things evolve in a way where we can’t concentrate on interstate shipping, we’ll have other resources to satisfy people’s requirements without putting ourselves in trouble.”
